COMPLEMENTARY LYMPHADENECTOMY IN MELANOMA: A REVIEW OF THE MSLTII STUDY

Authors

DOI:

https://doi.org/10.51891/rease.v12i11.32402

Keywords:

Melanoma, Sentinel Lymph Node, Lymph Node Dissection, MSLTII Trial, Public Health

Abstract

Cutaneous melanoma accounts for the highest mortality among skin cancers, demanding accurate staging and precise surgical management. Historically, sentinel lymph node biopsy (SLNB) positivity mandated immediate completion lymph node dissection. However, the Multicenter Selective Lymphadenectomy Trial II (MSLTII) shifted this paradigm by demonstrating overall survival equivalence between immediate completion dissection and active nodal observation using Doppler ultrasonography. This article reviews the MSLTII trial findings and evaluates its clinical applicability within the Brazilian Public Health System (SUS). Based on literature review and guidelines from the Brazilian Melanoma Group, we highlight that the lack of public coverage for adjuvant immunotherapy (e.g., ipilimumab) and targeted therapies restricts the direct application of MSLTII protocols in Brazil. Consequently, management of SLN-positive patients in SUS requires individualized decision-making, supported by predictive nomograms (such as Bertolli et al.) to stratify non-sentinel node involvement risk and guide surgical intervention.

 

0 0

Downloads

Download data is not yet available.

Author Biographies

  • Luiza Lira, Centro Universitário Assis Gurgacz

    Médica.Graduada pelo Centro Universitário Assis Gurgacz (FAG).  .   

  • Sabrina Nogueira Rodrigues, Centro Universitário FAG

    Médica. Graduada pelo Centro Universitário FAG. 

  • Amanda Suptitz de Almeida, Centro Universitário FAG

    Aluna de Curso de Medicina do Centro Universitário FAG. 

  • Heloisa Suptitz de Almeida, Centro Universitário FAG

    Aluna de Curso de Medicina do Centro Universitário FAG. 

  • Eduardo Miguel Prata Madureira, Centro Universitário Fundação Assis Gurgacz

    Orientador. Professor do Centro Universitário Assis Gurgacz.  Economista. Doutorando em Desenvolvimento Rural Sustentável. 

  • Mariana Taís Ferreira Moreira, Universidade Federal do Paraná

    Coorientadora: Médica. Graduada pela Universidade Federal do Paraná (2010). Cirurgiã Geral pelo Hospital Universitário Cajuru e Cirurgiã Oncológica pelo Hospital Erasto Gaertner. 

Published

2026-11-18

How to Cite

Lira, L., Rodrigues, S. N., Almeida, A. S. de, Almeida, H. S. de, Madureira, E. M. P., & Moreira, M. T. F. (2026). COMPLEMENTARY LYMPHADENECTOMY IN MELANOMA: A REVIEW OF THE MSLTII STUDY. Revista Ibero-Americana de Humanidades, Ciências E Educação, 12(11), 1-7. https://doi.org/10.51891/rease.v12i11.32402

Most read articles by the same author(s)

1-10 of 36

Similar Articles

1-10 of 50

You may also start an advanced similarity search for this article.